A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
01/2007
01/02/2007	US7157243 DNA encoding mammalian T-type calcium channels
01/02/2007	US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor
01/02/2007	US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection
01/02/2007	US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target
01/02/2007	US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
01/02/2007	CA2237059C Targeted adenovirus vectors
12/2006
12/30/2006	CA2511200A1 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing uch-l1 activity and methods for identifying enhancers of uch-l1 activity
12/28/2006	WO2006138675A2 Her-2 peptides
12/28/2006	WO2006138380A2 Amine-containing lipids and uses thereof
12/28/2006	WO2006137847A2 Engineered enzymatically active bacteriophages and methods of uses thereof
12/28/2006	WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances
12/28/2006	WO2006137517A1 Vector for gene transfer into young individual
12/28/2006	WO2006137515A1 Therapeutic agent for cancer comprising polypeptide capable of inhibiting the function of synoviolin as active ingredient
12/28/2006	WO2006137514A1 Therapeutic agent for cancer comprising substance capable of inhibiting expression or function of synoviolin as active ingredient and screening method for the therapeutic agent for cancer
12/28/2006	WO2006136114A1 Amniotic cells and methods for use thereof
12/28/2006	WO2006135969A1 Modulation of sphingosine kinase signalling
12/28/2006	WO2006135968A1 Modulation of sphingosine kinase signalling
12/28/2006	WO2006135967A1 Modulation of egfr signalling by modulation of sphingosine kinase signalling
12/28/2006	WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006	WO2005084712A3 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
12/28/2006	WO2005079271A3 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
12/28/2006	WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene
12/28/2006	WO2005009337A3 Treating severe acute respiratory syndrome
12/28/2006	US20060294617 Zinc finger proteins for DNA binding and gene regulation in plants
12/28/2006	US20060294615 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer
12/28/2006	US20060294614 Orphan receptors; drug screening; host cells
12/28/2006	US20060294601 Compositions, organisms and methodologies employing a novel human kinase
12/28/2006	US20060293272 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060293271 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060293270 Methods and compositions for treating ocular disorders
12/28/2006	US20060293269 oligonucleotide with modified phosphorothioate linkage, sugar moiety, or nucleobase; disease or condition associated with expression of superoxide dismutase 1
12/28/2006	US20060293268 Antisense antiviral compounds and methods for treating foot and mouth disease
12/28/2006	US20060293267 Dual functional oligonucleotides for use as anti-viral agents
12/28/2006	US20060293266 Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
12/28/2006	US20060293265 Methods involving aldose reductase inhibitors
12/28/2006	US20060293264 STAT3 decoy oligonucleotides and uses therefor
12/28/2006	US20060293263 Preparation for preventing contact of pathogenic matter with living organism
12/28/2006	US20060293262 inhibiting HIV entry into CCR5-expressing cells; treatment and prevention of infectious diseases or disorders, e.g., HIV infection, AIDS, and AIDS-related diseases
12/28/2006	US20060293256 Remedy or preventive for kidney disease and method of diagnosing kidney disease
12/28/2006	US20060293240 Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
12/28/2006	US20060293230 Expression and secretion of icIL-1 receptor antagonist type II
12/28/2006	US20060293225 Gmg-2 polynucleotides and polypeptides and uses thereof
12/28/2006	US20060292691 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/28/2006	US20060292670 Nell peptide expression systems and bone formation activity of nell peptide
12/28/2006	US20060292622 determining the presence of or predisposition to early-onset spinocerebellar ataxia with ocular motor aprataxia and hypoalbuminemia in a human; neurodegenerative disease
12/28/2006	US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006	US20060292566 Method for optimising gene expressing using synonymous codon optimisation
12/28/2006	US20060292563 Methods of diagnosing & treating diabetes and insulin resistance
12/28/2006	US20060292224 Pharmaceutical composition
12/28/2006	US20060292183 forming oil in water emulsions containing drugs by heating nanostructure particle size matrices, surfactants and drugs, then cooling while stirring
12/28/2006	US20060292177 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/28/2006	US20060292169 Fusion proteins of mycobacterium tuberculosis antigens and their uses
12/28/2006	US20060292157 MDA-7 protein variants having antiproliferative activity
12/28/2006	US20060292155 Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp)
12/28/2006	US20060292143 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/28/2006	US20060292132 Neuroprotective effective compound
12/28/2006	US20060292131 Chondrocyte Therapeutic Delivery System
12/28/2006	US20060292130 2-O sulfatase nucleic acid compositions
12/28/2006	US20060292129 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof
12/28/2006	US20060292128 Methods of treating schizophrenia
12/28/2006	US20060292123 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
12/28/2006	US20060292122 Adenoviral vectors for treating diseases
12/28/2006	US20060292121 Retroviral vectors including modified envelope escort protein
12/28/2006	US20060292120 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
12/28/2006	US20060292119 comprises negative immune regulator selected from a protein involved in molecular stability by ubiquitination, deubiquitination, and sumoylation, and a transcription factor that induces the expression of inhibitors of NF kappa B or suppresses transcription of NF kappa B targeted genes; vaccines
12/28/2006	US20060292118 Hollow nanoparticles of protein and drug using the same
12/28/2006	US20060292117 Improved rAAv vectors
12/28/2006	US20060292115 Methods and compositions for treating and preventing inflammatory conditions
12/28/2006	US20060292113 Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer
12/28/2006	CA2620946A1 Amniotic cells and methods for use thereof
12/28/2006	CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof
12/28/2006	CA2612773A1 Modulation of sphingosine kinase signalling
12/28/2006	CA2612644A1 Modulation of sphingosine kinase signalling
12/28/2006	CA2612640A1 Modulation of egfr signalling by modulation of sphingosine kinase signalling
12/28/2006	CA2612394A1 Her-2 peptides
12/28/2006	CA2612389A1 Genemap of the human genes associated with longevity
12/28/2006	CA2611944A1 Amine-containing lipids and uses thereof
12/28/2006	CA2587189A1 Methods and compositions involving mirna and mirna inhibitor molecules
12/27/2006	EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736541A1 Novel galectin 9 modification protein and use thereof
12/27/2006	EP1736501A1 Peg-functional nucleic acid conjugate
12/27/2006	EP1736172A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
12/27/2006	EP1736171A1 Antiobesity drug
12/27/2006	EP1736168A1 Protease inhibitor and preventives or remedies for diseases
12/27/2006	EP1736162A1 Remedy for prion disease and method of producing the same
12/27/2006	EP1735448A2 Inducible dimerization of growth factor receptors for treating cancer
12/27/2006	EP1735445A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
12/27/2006	EP1735444A2 Methods and compositions for the treatment of obesity
12/27/2006	EP1735441A1 Therapeutic molecules for modulating stability of vegf transcripts
12/27/2006	EP1735435A1 Methods and compositions involving s-ship promoter regions
12/27/2006	EP1735011A2 Method of modulating vascularization
12/27/2006	EP1735010A2 Methods, compositions, and preparations for delivery of immune response modifiers
12/27/2006	EP1735009A2 iRNA AGENTS TARGETING VEGF
12/27/2006	EP1734828A1 Genetically modified heart valve xenografts
12/27/2006	EP1734827A2 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
12/27/2006	EP1734814A2 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
12/27/2006	EP1507873A4 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/27/2006	EP1507863B1 Plasmid stabilisation in vivo
12/27/2006	EP1373500B1 Gene involved in v(d)j recombination and/or dna repair

1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 870